Phibro Animal Health’s Return On Capital Employed Insights
According to Benzinga Pro, during Q2, Phibro Animal Health (NASDAQ:PAHC) earned $7.21 million, a 86.98% increase from the…
Phibro Animal Health Q2 EPS $0.34 Beats $0.30 Estimate, Sales $244.60M Beat $241.28M Estimate
Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.30 by 13.33 percent. This is a 8.11 percent decrease over earnings of $0.37 per share from
Benzinga’s Top Ratings Upgrades, Downgrades For December 21, 2022
Upgrades For PagSeguro Digital Ltd (NYSE:PAGS), New Street Research upgraded the previous rating of Neutral to Buy. In…
Roth Capital Initiates Coverage On Phibro Animal Health with Buy Rating, Announces Price Target of $18
Roth Capital analyst Brian Wright initiates coverage on Phibro Animal Health (NASDAQ:PAHC) with a Buy rating and announces Price Target of $18.
